AbCellera Biologics (ABCL) Treasury Shares (2021 - 2026)
AbCellera Biologics (ABCL) reported Treasury Shares of $10.1 million for Q1 2026, up 4.2% on a YoY basis from $9.7 million in Q1 2025, and up 12.61% quarter-over-quarter from $9.0 million in Q3 2025.
AbCellera Biologics (ABCL) Treasury Shares (2021 - 2026) Analysis & Trends
AbCellera Biologics has reported Treasury Shares for 6 years, with the latest figure at $10.1 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | AbCellera Biologics | 1.55 Bn | 1.44 Bn | - | 10.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.14 Mn |
| Mar 31, 2026 | 10.14 Mn |
| Sep 30, 2025 | 9.00 Mn |
| Sep 30, 2025 | 9.00 Mn |
| Jun 30, 2025 | 9.39 Mn |
| Jun 30, 2025 | 9.39 Mn |
| Mar 31, 2025 | 9.73 Mn |
| Mar 31, 2025 | 9.73 Mn |
| Sep 30, 2024 | 6.85 Mn |
| Sep 30, 2024 | 6.85 Mn |
| Jun 30, 2024 | 7.03 Mn |
| Jun 30, 2024 | 7.03 Mn |
| Mar 31, 2024 | 7.10 Mn |
| Mar 31, 2024 | 7.10 Mn |
| Sep 30, 2023 | 4.42 Mn |
| Sep 30, 2023 | 4.42 Mn |
| Jun 30, 2023 | 4.59 Mn |
| Jun 30, 2023 | 4.59 Mn |
| Mar 31, 2023 | 4.43 Mn |
| Mar 31, 2023 | 4.43 Mn |